7-152177495-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_170606.3(KMT2C):​c.7958T>C​(p.Leu2653Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00155 in 1,614,174 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L2653V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0079 ( 12 hom., cov: 31)
Exomes 𝑓: 0.00089 ( 31 hom. )

Consequence

KMT2C
NM_170606.3 missense

Scores

1
16

Clinical Significance

Benign criteria provided, single submitter B:2O:1

Conservation

PhyloP100: 3.29

Publications

4 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0021421313).
BP6
Variant 7-152177495-A-G is Benign according to our data. Variant chr7-152177495-A-G is described in ClinVar as Benign. ClinVar VariationId is 134781.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00787 (1199/152288) while in subpopulation AFR AF = 0.028 (1165/41562). AF 95% confidence interval is 0.0267. There are 12 homozygotes in GnomAd4. There are 583 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1199 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2CNM_170606.3 linkc.7958T>C p.Leu2653Pro missense_variant Exon 38 of 59 ENST00000262189.11 NP_733751.2 Q8NEZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2CENST00000262189.11 linkc.7958T>C p.Leu2653Pro missense_variant Exon 38 of 59 1 NM_170606.3 ENSP00000262189.6 Q8NEZ4-1

Frequencies

GnomAD3 genomes
AF:
0.00787
AC:
1197
AN:
152170
Hom.:
12
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0281
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00177
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00221
AC:
556
AN:
251286
AF XY:
0.00162
show subpopulations
Gnomad AFR exome
AF:
0.0301
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.000887
AC:
1297
AN:
1461886
Hom.:
31
Cov.:
35
AF XY:
0.000799
AC XY:
581
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0313
AC:
1048
AN:
33480
American (AMR)
AF:
0.00168
AC:
75
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000567
AC:
63
AN:
1112004
Other (OTH)
AF:
0.00167
AC:
101
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
80
160
240
320
400
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00787
AC:
1199
AN:
152288
Hom.:
12
Cov.:
31
AF XY:
0.00783
AC XY:
583
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0280
AC:
1165
AN:
41562
American (AMR)
AF:
0.00176
AC:
27
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68016
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00529
Hom.:
10
Bravo
AF:
0.00932
ESP6500AA
AF:
0.0309
AC:
136
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00275
AC:
334
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

KMT2C-related disorder Benign:1
Sep 09, 2022
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
18
DANN
Benign
0.29
DEOGEN2
Benign
0.053
T;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.72
.;T
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
1.5
L;L
PhyloP100
3.3
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.2
N;N
REVEL
Uncertain
0.32
Sift
Benign
0.14
T;T
Polyphen
0.0010
B;B
Vest4
0.071
MVP
0.48
MPC
0.13
ClinPred
0.015
T
GERP RS
4.5
Varity_R
0.12
gMVP
0.29
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61730547; hg19: chr7-151874580; API